The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
During the HLH portion of the How I Treat or Manage session at 9.00-9.20 on 4 March, Dr. Gohil will discuss how the HLH multidisciplinary advisory panel works and the ways in which it can support clinicians.
SOHO Insider is pleased to announce two new upcoming sessions in our Community Oncology Brown Bag Series, hosted by Loretta J. Nastoupil, MD.
Daniel Zheng, MD, a pediatric oncologist at the Children’s Hospital of Philadelphia, and Chiara Bona, MD, a pediatric oncologist at Dana-Farber Boston Children’s Cancer and Blood Disorders Center, discuss their research on financial toxicity in pediatric leukemia.
Var-cel was approved in 2021 in Spain for patients ages 25 years and older with relapsed or refractory B-cell precursor ALL.
Dr. Manson covers the importance of treating the underlying driver of HLH to prevent recurrence and improve patient outcomes. She also highlights resources like the “Getting It Right First Time” (GURFT) guidelines and the Hi-HASK collaboration.
To access the SOHO Career Center click the following link.
